BACKGROUNDPatch testing remains the gold standard method for the identification of the
etiologic agent of allergic contact dermatitis. However, it is a subjective,
time-consuming exam whose technique demands special care and which presents some
contraindications, which hamper its use. In a recent study, we showed that the
proliferation assay can suitably replace patch testing for the diagnosis of
chromium allergy, which had been previously demonstrated only for nickel allergy.
In this study, we try to refine the method by reducing the incubation period of
cultures for lymphocyte proliferation assays in response to chromium. OBJECTIVEDevelop an alternative or complementary diagnostic test for chromium allergic
contact dermatitis.METHODSWe compared the production of 9 cytokines (IFN-γ, IL-2, IL-4, IL-5, IL-10, IL-12,
IL-13, IL-17 and RANTES) between 18 chromium-allergic patients and 19 controls.
RESULTSChromium increased the production of IFN-y, IL-5, IL-2 and IL-13 in allergic
patients, but only IL-2 and especially IL-13 helped discriminate allergic patients
from controls. The sensitivity, specificity and accuracy found with IL-13 were
about 80%. CONCLUSIONS IL-13 and IL-2 detection may be used to diagnose chromium allergy in 2-day
cultures. However, in general, the 6-day cultures seem to be superior for this
purpose.